GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » NonCurrent Deferred Liabilities

EirGenix (ROCO:6589) NonCurrent Deferred Liabilities : NT$0.0 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is EirGenix NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

EirGenix's non-current deferred liabilities for the quarter that ended in Mar. 2025 was NT$0.0 Mil.

EirGenix NonCurrent Deferred Liabilities Historical Data

The historical data trend for EirGenix's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix NonCurrent Deferred Liabilities Chart

EirGenix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EirGenix Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

EirGenix NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of EirGenix's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

EirGenix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
ROCO:4147 ROCO:6547 ROCO:4728 ROCO:6617 ROCO:6712 TPE:6541 ROCO:4162 ROCO:6696 ROCO:6535 ROCO:6976 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
Website
https://www.eirgenix.com
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Furthermore, the company has two PIC/S GMP facilities, one for mammalian cells and one for microbial, to provide clinical trial drug and commercial drug production. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST.

EirGenix Headlines

No Headlines